Home Infliximab Infusions Are Associated With Suboptimal Outcomes Without Cost Savings
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The American Journal of Gastroenterology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Home Infliximab Infusions Are Associated With Suboptimal Outcomes Without Cost Savings in Inflammatory Bowel Diseases
Am. J. Gastroenterol 2020 Oct 01;115(10)1698-1706, N Giese-Kim, M Wu, M Dehghan, LA Sceats, KT ParkFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.